WILMINGTON, Del.--(BUSINESS WIRE)--Jan. 24, 2023--
Incyte (Nasdaq:INCY) announced today that it will present at the Guggenheim Healthcare Talks l Oncology Day on Wednesday, February 8, 2023 at 1:35 p.m. (EST) in New York.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230124005025/en/
+1 302 498 6171
+1 302 274 4773